FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon, Inc., a clinical-stage biopharmaceutical company developing a broad portfolio of investigational therapies and diagnostic assays for patients with ...

Jeremy has more than 2300 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

Donald Trump has insisted he doesn’t need to abide by international law and the only constraint keeping his power in check is his own morality. In a wide-ranging defence of a week of global ...

Editing function to be limited to paying subscribers after X threatened with fines and regulatory action Grok, Elon Musk’s AI tool, has switched off its image creation function for the vast majority ...

After a volatile stretch for bitcoin BTC $74,034.21 in October and November 2025, the world’s largest cryptocurrency has been showing signs of stabilization, trading in the roughly $85,000-$90,000 ...

In the vacillating contours of US President Donald Trump’s foreign policy, little should surprise. And outlying moments of apparent success against Iran’s nuclear program (even if short-lived), are ...

This post is part two of a series. Executive Function (EF) challenges or delays in mastering EF skills almost always accompany ADHD. There can be many different aspects to EF challenges that may be ...

Some donors threatened to pull support from universities last year over mounting pro-Palestinian protests. But private gifts are just one way schools are funded. Former Northwestern President Morton ...

Tesla is facing a new scandal that once again sees the electric automaker accused of misleading customers. In the past, it has been caught making “misleading statements” about the safety of its ...

One in four young Australians are being plagued by a problem that is “actively hurting” Australian workplaces’ bottom line, costing them $6.8 billion every year. Research by News Corp’s Growth ...